Global Genetic Toxicology Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Genetic Toxicology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Genetic Toxicology market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Genetic Toxicology market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Mini Ames/Ames occupied for % of the Genetic Toxicology global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Genotoxicity Screening Assays segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Toxicology include Frontage Laboratories, Accelera, Charles River, Pharmaron and Labcorp, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Genetic Toxicology market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Genetic Toxicology companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Genetic Toxicology market based on the following parameters – headquarters, products portfolio, Genetic Toxicology revenue and gross margin, recent developments.
Evaluation and forecast the Genetic Toxicology market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Genetic Toxicology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Genetic Toxicology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Toxicology, with revenue, gross margin and global market share of Genetic Toxicology from 2019 to 2022.
Chapter 3, the Genetic Toxicology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Toxicology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Toxicology research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Genetic Toxicology market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Genetic Toxicology market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Mini Ames/Ames occupied for % of the Genetic Toxicology global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Genotoxicity Screening Assays segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Toxicology include Frontage Laboratories, Accelera, Charles River, Pharmaron and Labcorp, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Genetic Toxicology market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Genetic Toxicology companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Genetic Toxicology market based on the following parameters – headquarters, products portfolio, Genetic Toxicology revenue and gross margin, recent developments.
Evaluation and forecast the Genetic Toxicology market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Genetic Toxicology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Genotoxicity Screening Assays
- GLP Standard Genotoxicity Assays
- Mini Ames/Ames
- Gene Mutation
- In Vitro Micronucleus
- Chromosome Aberration
- Others
- Frontage Laboratories
- Accelera
- Charles River
- Pharmaron
- Labcorp
- Syngene
- Vivotecnia
- Technics
- Aurigene Pharmaceutical Services
- ERBC Group
- NextGen
- Cardinal Health
- Toxys
- Abbott Toxicology
- Evotec
- EPL
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Genetic Toxicology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Toxicology, with revenue, gross margin and global market share of Genetic Toxicology from 2019 to 2022.
Chapter 3, the Genetic Toxicology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Toxicology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Toxicology research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Genetic Toxicology
1.2 Classification of Genetic Toxicology by Type
1.2.1 Overview: Global Genetic Toxicology Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genetic Toxicology Revenue Market Share by Type in 2021
1.2.3 Genotoxicity Screening Assays
1.2.4 GLP Standard Genotoxicity Assays
1.3 Global Genetic Toxicology Market by Application
1.3.1 Overview: Global Genetic Toxicology Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Mini Ames/Ames
1.3.3 Gene Mutation
1.3.4 In Vitro Micronucleus
1.3.5 Chromosome Aberration
1.3.6 Others
1.4 Global Genetic Toxicology Market Size & Forecast
1.5 Global Genetic Toxicology Market Size and Forecast by Region
1.5.1 Global Genetic Toxicology Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genetic Toxicology Market Size by Region, (2017-2022)
1.5.3 North America Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.4 Europe Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.6 South America Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genetic Toxicology Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Toxicology Market Drivers
1.6.2 Genetic Toxicology Market Restraints
1.6.3 Genetic Toxicology Trends Analysis
2 COMPANY PROFILES
2.1 Frontage Laboratories
2.1.1 Frontage Laboratories Details
2.1.2 Frontage Laboratories Major Business
2.1.3 Frontage Laboratories Genetic Toxicology Product and Solutions
2.1.4 Frontage Laboratories Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Frontage Laboratories Recent Developments and Future Plans
2.2 Accelera
2.2.1 Accelera Details
2.2.2 Accelera Major Business
2.2.3 Accelera Genetic Toxicology Product and Solutions
2.2.4 Accelera Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Accelera Recent Developments and Future Plans
2.3 Charles River
2.3.1 Charles River Details
2.3.2 Charles River Major Business
2.3.3 Charles River Genetic Toxicology Product and Solutions
2.3.4 Charles River Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Recent Developments and Future Plans
2.4 Pharmaron
2.4.1 Pharmaron Details
2.4.2 Pharmaron Major Business
2.4.3 Pharmaron Genetic Toxicology Product and Solutions
2.4.4 Pharmaron Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pharmaron Recent Developments and Future Plans
2.5 Labcorp
2.5.1 Labcorp Details
2.5.2 Labcorp Major Business
2.5.3 Labcorp Genetic Toxicology Product and Solutions
2.5.4 Labcorp Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Labcorp Recent Developments and Future Plans
2.6 Syngene
2.6.1 Syngene Details
2.6.2 Syngene Major Business
2.6.3 Syngene Genetic Toxicology Product and Solutions
2.6.4 Syngene Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Syngene Recent Developments and Future Plans
2.7 Vivotecnia
2.7.1 Vivotecnia Details
2.7.2 Vivotecnia Major Business
2.7.3 Vivotecnia Genetic Toxicology Product and Solutions
2.7.4 Vivotecnia Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Vivotecnia Recent Developments and Future Plans
2.8 Technics
2.8.1 Technics Details
2.8.2 Technics Major Business
2.8.3 Technics Genetic Toxicology Product and Solutions
2.8.4 Technics Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Technics Recent Developments and Future Plans
2.9 Aurigene Pharmaceutical Services
2.9.1 Aurigene Pharmaceutical Services Details
2.9.2 Aurigene Pharmaceutical Services Major Business
2.9.3 Aurigene Pharmaceutical Services Genetic Toxicology Product and Solutions
2.9.4 Aurigene Pharmaceutical Services Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
2.10 ERBC Group
2.10.1 ERBC Group Details
2.10.2 ERBC Group Major Business
2.10.3 ERBC Group Genetic Toxicology Product and Solutions
2.10.4 ERBC Group Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 ERBC Group Recent Developments and Future Plans
2.11 NextGen
2.11.1 NextGen Details
2.11.2 NextGen Major Business
2.11.3 NextGen Genetic Toxicology Product and Solutions
2.11.4 NextGen Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 NextGen Recent Developments and Future Plans
2.12 Cardinal Health
2.12.1 Cardinal Health Details
2.12.2 Cardinal Health Major Business
2.12.3 Cardinal Health Genetic Toxicology Product and Solutions
2.12.4 Cardinal Health Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cardinal Health Recent Developments and Future Plans
2.13 Toxys
2.13.1 Toxys Details
2.13.2 Toxys Major Business
2.13.3 Toxys Genetic Toxicology Product and Solutions
2.13.4 Toxys Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Toxys Recent Developments and Future Plans
2.14 Abbott Toxicology
2.14.1 Abbott Toxicology Details
2.14.2 Abbott Toxicology Major Business
2.14.3 Abbott Toxicology Genetic Toxicology Product and Solutions
2.14.4 Abbott Toxicology Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Abbott Toxicology Recent Developments and Future Plans
2.15 Evotec
2.15.1 Evotec Details
2.15.2 Evotec Major Business
2.15.3 Evotec Genetic Toxicology Product and Solutions
2.15.4 Evotec Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Evotec Recent Developments and Future Plans
2.16 EPL
2.16.1 EPL Details
2.16.2 EPL Major Business
2.16.3 EPL Genetic Toxicology Product and Solutions
2.16.4 EPL Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 EPL Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Toxicology Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Toxicology Players Market Share in 2021
3.2.2 Top 10 Genetic Toxicology Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genetic Toxicology Players Head Office, Products and Services Provided
3.4 Genetic Toxicology Mergers & Acquisitions
3.5 Genetic Toxicology New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Toxicology Revenue and Market Share by Type (2017-2022)
4.2 Global Genetic Toxicology Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Toxicology Revenue Market Share by Application (2017-2022)
5.2 Global Genetic Toxicology Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Genetic Toxicology Revenue by Type (2017-2028)
6.2 North America Genetic Toxicology Revenue by Application (2017-2028)
6.3 North America Genetic Toxicology Market Size by Country
6.3.1 North America Genetic Toxicology Revenue by Country (2017-2028)
6.3.2 United States Genetic Toxicology Market Size and Forecast (2017-2028)
6.3.3 Canada Genetic Toxicology Market Size and Forecast (2017-2028)
6.3.4 Mexico Genetic Toxicology Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Genetic Toxicology Revenue by Type (2017-2028)
7.2 Europe Genetic Toxicology Revenue by Application (2017-2028)
7.3 Europe Genetic Toxicology Market Size by Country
7.3.1 Europe Genetic Toxicology Revenue by Country (2017-2028)
7.3.2 Germany Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.3 France Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.5 Russia Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.6 Italy Genetic Toxicology Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Genetic Toxicology Revenue by Type (2017-2028)
8.2 Asia-Pacific Genetic Toxicology Revenue by Application (2017-2028)
8.3 Asia-Pacific Genetic Toxicology Market Size by Region
8.3.1 Asia-Pacific Genetic Toxicology Revenue by Region (2017-2028)
8.3.2 China Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.3 Japan Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.4 South Korea Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.5 India Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.7 Australia Genetic Toxicology Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Genetic Toxicology Revenue by Type (2017-2028)
9.2 South America Genetic Toxicology Revenue by Application (2017-2028)
9.3 South America Genetic Toxicology Market Size by Country
9.3.1 South America Genetic Toxicology Revenue by Country (2017-2028)
9.3.2 Brazil Genetic Toxicology Market Size and Forecast (2017-2028)
9.3.3 Argentina Genetic Toxicology Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Genetic Toxicology Revenue by Type (2017-2028)
10.2 Middle East & Africa Genetic Toxicology Revenue by Application (2017-2028)
10.3 Middle East & Africa Genetic Toxicology Market Size by Country
10.3.1 Middle East & Africa Genetic Toxicology Revenue by Country (2017-2028)
10.3.2 Turkey Genetic Toxicology Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genetic Toxicology Market Size and Forecast (2017-2028)
10.3.4 UAE Genetic Toxicology Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Genetic Toxicology
1.2 Classification of Genetic Toxicology by Type
1.2.1 Overview: Global Genetic Toxicology Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genetic Toxicology Revenue Market Share by Type in 2021
1.2.3 Genotoxicity Screening Assays
1.2.4 GLP Standard Genotoxicity Assays
1.3 Global Genetic Toxicology Market by Application
1.3.1 Overview: Global Genetic Toxicology Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Mini Ames/Ames
1.3.3 Gene Mutation
1.3.4 In Vitro Micronucleus
1.3.5 Chromosome Aberration
1.3.6 Others
1.4 Global Genetic Toxicology Market Size & Forecast
1.5 Global Genetic Toxicology Market Size and Forecast by Region
1.5.1 Global Genetic Toxicology Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genetic Toxicology Market Size by Region, (2017-2022)
1.5.3 North America Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.4 Europe Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.6 South America Genetic Toxicology Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genetic Toxicology Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Toxicology Market Drivers
1.6.2 Genetic Toxicology Market Restraints
1.6.3 Genetic Toxicology Trends Analysis
2 COMPANY PROFILES
2.1 Frontage Laboratories
2.1.1 Frontage Laboratories Details
2.1.2 Frontage Laboratories Major Business
2.1.3 Frontage Laboratories Genetic Toxicology Product and Solutions
2.1.4 Frontage Laboratories Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Frontage Laboratories Recent Developments and Future Plans
2.2 Accelera
2.2.1 Accelera Details
2.2.2 Accelera Major Business
2.2.3 Accelera Genetic Toxicology Product and Solutions
2.2.4 Accelera Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Accelera Recent Developments and Future Plans
2.3 Charles River
2.3.1 Charles River Details
2.3.2 Charles River Major Business
2.3.3 Charles River Genetic Toxicology Product and Solutions
2.3.4 Charles River Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Recent Developments and Future Plans
2.4 Pharmaron
2.4.1 Pharmaron Details
2.4.2 Pharmaron Major Business
2.4.3 Pharmaron Genetic Toxicology Product and Solutions
2.4.4 Pharmaron Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pharmaron Recent Developments and Future Plans
2.5 Labcorp
2.5.1 Labcorp Details
2.5.2 Labcorp Major Business
2.5.3 Labcorp Genetic Toxicology Product and Solutions
2.5.4 Labcorp Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Labcorp Recent Developments and Future Plans
2.6 Syngene
2.6.1 Syngene Details
2.6.2 Syngene Major Business
2.6.3 Syngene Genetic Toxicology Product and Solutions
2.6.4 Syngene Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Syngene Recent Developments and Future Plans
2.7 Vivotecnia
2.7.1 Vivotecnia Details
2.7.2 Vivotecnia Major Business
2.7.3 Vivotecnia Genetic Toxicology Product and Solutions
2.7.4 Vivotecnia Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Vivotecnia Recent Developments and Future Plans
2.8 Technics
2.8.1 Technics Details
2.8.2 Technics Major Business
2.8.3 Technics Genetic Toxicology Product and Solutions
2.8.4 Technics Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Technics Recent Developments and Future Plans
2.9 Aurigene Pharmaceutical Services
2.9.1 Aurigene Pharmaceutical Services Details
2.9.2 Aurigene Pharmaceutical Services Major Business
2.9.3 Aurigene Pharmaceutical Services Genetic Toxicology Product and Solutions
2.9.4 Aurigene Pharmaceutical Services Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Aurigene Pharmaceutical Services Recent Developments and Future Plans
2.10 ERBC Group
2.10.1 ERBC Group Details
2.10.2 ERBC Group Major Business
2.10.3 ERBC Group Genetic Toxicology Product and Solutions
2.10.4 ERBC Group Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 ERBC Group Recent Developments and Future Plans
2.11 NextGen
2.11.1 NextGen Details
2.11.2 NextGen Major Business
2.11.3 NextGen Genetic Toxicology Product and Solutions
2.11.4 NextGen Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 NextGen Recent Developments and Future Plans
2.12 Cardinal Health
2.12.1 Cardinal Health Details
2.12.2 Cardinal Health Major Business
2.12.3 Cardinal Health Genetic Toxicology Product and Solutions
2.12.4 Cardinal Health Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cardinal Health Recent Developments and Future Plans
2.13 Toxys
2.13.1 Toxys Details
2.13.2 Toxys Major Business
2.13.3 Toxys Genetic Toxicology Product and Solutions
2.13.4 Toxys Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Toxys Recent Developments and Future Plans
2.14 Abbott Toxicology
2.14.1 Abbott Toxicology Details
2.14.2 Abbott Toxicology Major Business
2.14.3 Abbott Toxicology Genetic Toxicology Product and Solutions
2.14.4 Abbott Toxicology Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Abbott Toxicology Recent Developments and Future Plans
2.15 Evotec
2.15.1 Evotec Details
2.15.2 Evotec Major Business
2.15.3 Evotec Genetic Toxicology Product and Solutions
2.15.4 Evotec Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Evotec Recent Developments and Future Plans
2.16 EPL
2.16.1 EPL Details
2.16.2 EPL Major Business
2.16.3 EPL Genetic Toxicology Product and Solutions
2.16.4 EPL Genetic Toxicology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 EPL Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Toxicology Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Toxicology Players Market Share in 2021
3.2.2 Top 10 Genetic Toxicology Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genetic Toxicology Players Head Office, Products and Services Provided
3.4 Genetic Toxicology Mergers & Acquisitions
3.5 Genetic Toxicology New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Toxicology Revenue and Market Share by Type (2017-2022)
4.2 Global Genetic Toxicology Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Toxicology Revenue Market Share by Application (2017-2022)
5.2 Global Genetic Toxicology Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Genetic Toxicology Revenue by Type (2017-2028)
6.2 North America Genetic Toxicology Revenue by Application (2017-2028)
6.3 North America Genetic Toxicology Market Size by Country
6.3.1 North America Genetic Toxicology Revenue by Country (2017-2028)
6.3.2 United States Genetic Toxicology Market Size and Forecast (2017-2028)
6.3.3 Canada Genetic Toxicology Market Size and Forecast (2017-2028)
6.3.4 Mexico Genetic Toxicology Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Genetic Toxicology Revenue by Type (2017-2028)
7.2 Europe Genetic Toxicology Revenue by Application (2017-2028)
7.3 Europe Genetic Toxicology Market Size by Country
7.3.1 Europe Genetic Toxicology Revenue by Country (2017-2028)
7.3.2 Germany Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.3 France Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.5 Russia Genetic Toxicology Market Size and Forecast (2017-2028)
7.3.6 Italy Genetic Toxicology Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Genetic Toxicology Revenue by Type (2017-2028)
8.2 Asia-Pacific Genetic Toxicology Revenue by Application (2017-2028)
8.3 Asia-Pacific Genetic Toxicology Market Size by Region
8.3.1 Asia-Pacific Genetic Toxicology Revenue by Region (2017-2028)
8.3.2 China Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.3 Japan Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.4 South Korea Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.5 India Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genetic Toxicology Market Size and Forecast (2017-2028)
8.3.7 Australia Genetic Toxicology Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Genetic Toxicology Revenue by Type (2017-2028)
9.2 South America Genetic Toxicology Revenue by Application (2017-2028)
9.3 South America Genetic Toxicology Market Size by Country
9.3.1 South America Genetic Toxicology Revenue by Country (2017-2028)
9.3.2 Brazil Genetic Toxicology Market Size and Forecast (2017-2028)
9.3.3 Argentina Genetic Toxicology Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Genetic Toxicology Revenue by Type (2017-2028)
10.2 Middle East & Africa Genetic Toxicology Revenue by Application (2017-2028)
10.3 Middle East & Africa Genetic Toxicology Market Size by Country
10.3.1 Middle East & Africa Genetic Toxicology Revenue by Country (2017-2028)
10.3.2 Turkey Genetic Toxicology Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genetic Toxicology Market Size and Forecast (2017-2028)
10.3.4 UAE Genetic Toxicology Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Genetic Toxicology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genetic Toxicology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genetic Toxicology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genetic Toxicology Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genetic Toxicology Revenue Market Share by Region (2023-2028)
Table 6. Frontage Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Frontage Laboratories Major Business
Table 8. Frontage Laboratories Genetic Toxicology Product and Solutions
Table 9. Frontage Laboratories Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Accelera Corporate Information, Head Office, and Major Competitors
Table 11. Accelera Major Business
Table 12. Accelera Genetic Toxicology Product and Solutions
Table 13. Accelera Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Major Business
Table 16. Charles River Genetic Toxicology Product and Solutions
Table 17. Charles River Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pharmaron Corporate Information, Head Office, and Major Competitors
Table 19. Pharmaron Major Business
Table 20. Pharmaron Genetic Toxicology Product and Solutions
Table 21. Pharmaron Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Labcorp Corporate Information, Head Office, and Major Competitors
Table 23. Labcorp Major Business
Table 24. Labcorp Genetic Toxicology Product and Solutions
Table 25. Labcorp Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Syngene Corporate Information, Head Office, and Major Competitors
Table 27. Syngene Major Business
Table 28. Syngene Genetic Toxicology Product and Solutions
Table 29. Syngene Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Vivotecnia Corporate Information, Head Office, and Major Competitors
Table 31. Vivotecnia Major Business
Table 32. Vivotecnia Genetic Toxicology Product and Solutions
Table 33. Vivotecnia Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Technics Corporate Information, Head Office, and Major Competitors
Table 35. Technics Major Business
Table 36. Technics Genetic Toxicology Product and Solutions
Table 37. Technics Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Aurigene Pharmaceutical Services Corporate Information, Head Office, and Major Competitors
Table 39. Aurigene Pharmaceutical Services Major Business
Table 40. Aurigene Pharmaceutical Services Genetic Toxicology Product and Solutions
Table 41. Aurigene Pharmaceutical Services Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. ERBC Group Corporate Information, Head Office, and Major Competitors
Table 43. ERBC Group Major Business
Table 44. ERBC Group Genetic Toxicology Product and Solutions
Table 45. ERBC Group Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. NextGen Corporate Information, Head Office, and Major Competitors
Table 47. NextGen Major Business
Table 48. NextGen Genetic Toxicology Product and Solutions
Table 49. NextGen Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 51. Cardinal Health Major Business
Table 52. Cardinal Health Genetic Toxicology Product and Solutions
Table 53. Cardinal Health Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Toxys Corporate Information, Head Office, and Major Competitors
Table 55. Toxys Major Business
Table 56. Toxys Genetic Toxicology Product and Solutions
Table 57. Toxys Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Abbott Toxicology Corporate Information, Head Office, and Major Competitors
Table 59. Abbott Toxicology Major Business
Table 60. Abbott Toxicology Genetic Toxicology Product and Solutions
Table 61. Abbott Toxicology Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Evotec Corporate Information, Head Office, and Major Competitors
Table 63. Evotec Major Business
Table 64. Evotec Genetic Toxicology Product and Solutions
Table 65. Evotec Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. EPL Corporate Information, Head Office, and Major Competitors
Table 67. EPL Major Business
Table 68. EPL Genetic Toxicology Product and Solutions
Table 69. EPL Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Genetic Toxicology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Genetic Toxicology Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Genetic Toxicology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Genetic Toxicology Players Head Office, Products and Services Provided
Table 74. Genetic Toxicology Mergers & Acquisitions in the Past Five Years
Table 75. Genetic Toxicology New Entrants and Expansion Plans
Table 76. Global Genetic Toxicology Revenue (USD Million) by Type (2017-2022)
Table 77. Global Genetic Toxicology Revenue Share by Type (2017-2022)
Table 78. Global Genetic Toxicology Revenue Forecast by Type (2023-2028)
Table 79. Global Genetic Toxicology Revenue by Application (2017-2022)
Table 80. Global Genetic Toxicology Revenue Forecast by Application (2023-2028)
Table 81. North America Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Genetic Toxicology Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Genetic Toxicology Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Genetic Toxicology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genetic Toxicology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genetic Toxicology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genetic Toxicology Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genetic Toxicology Revenue Market Share by Region (2023-2028)
Table 6. Frontage Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Frontage Laboratories Major Business
Table 8. Frontage Laboratories Genetic Toxicology Product and Solutions
Table 9. Frontage Laboratories Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Accelera Corporate Information, Head Office, and Major Competitors
Table 11. Accelera Major Business
Table 12. Accelera Genetic Toxicology Product and Solutions
Table 13. Accelera Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Major Business
Table 16. Charles River Genetic Toxicology Product and Solutions
Table 17. Charles River Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pharmaron Corporate Information, Head Office, and Major Competitors
Table 19. Pharmaron Major Business
Table 20. Pharmaron Genetic Toxicology Product and Solutions
Table 21. Pharmaron Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Labcorp Corporate Information, Head Office, and Major Competitors
Table 23. Labcorp Major Business
Table 24. Labcorp Genetic Toxicology Product and Solutions
Table 25. Labcorp Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Syngene Corporate Information, Head Office, and Major Competitors
Table 27. Syngene Major Business
Table 28. Syngene Genetic Toxicology Product and Solutions
Table 29. Syngene Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Vivotecnia Corporate Information, Head Office, and Major Competitors
Table 31. Vivotecnia Major Business
Table 32. Vivotecnia Genetic Toxicology Product and Solutions
Table 33. Vivotecnia Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Technics Corporate Information, Head Office, and Major Competitors
Table 35. Technics Major Business
Table 36. Technics Genetic Toxicology Product and Solutions
Table 37. Technics Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Aurigene Pharmaceutical Services Corporate Information, Head Office, and Major Competitors
Table 39. Aurigene Pharmaceutical Services Major Business
Table 40. Aurigene Pharmaceutical Services Genetic Toxicology Product and Solutions
Table 41. Aurigene Pharmaceutical Services Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. ERBC Group Corporate Information, Head Office, and Major Competitors
Table 43. ERBC Group Major Business
Table 44. ERBC Group Genetic Toxicology Product and Solutions
Table 45. ERBC Group Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. NextGen Corporate Information, Head Office, and Major Competitors
Table 47. NextGen Major Business
Table 48. NextGen Genetic Toxicology Product and Solutions
Table 49. NextGen Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 51. Cardinal Health Major Business
Table 52. Cardinal Health Genetic Toxicology Product and Solutions
Table 53. Cardinal Health Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Toxys Corporate Information, Head Office, and Major Competitors
Table 55. Toxys Major Business
Table 56. Toxys Genetic Toxicology Product and Solutions
Table 57. Toxys Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Abbott Toxicology Corporate Information, Head Office, and Major Competitors
Table 59. Abbott Toxicology Major Business
Table 60. Abbott Toxicology Genetic Toxicology Product and Solutions
Table 61. Abbott Toxicology Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Evotec Corporate Information, Head Office, and Major Competitors
Table 63. Evotec Major Business
Table 64. Evotec Genetic Toxicology Product and Solutions
Table 65. Evotec Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. EPL Corporate Information, Head Office, and Major Competitors
Table 67. EPL Major Business
Table 68. EPL Genetic Toxicology Product and Solutions
Table 69. EPL Genetic Toxicology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Genetic Toxicology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Genetic Toxicology Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Genetic Toxicology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Genetic Toxicology Players Head Office, Products and Services Provided
Table 74. Genetic Toxicology Mergers & Acquisitions in the Past Five Years
Table 75. Genetic Toxicology New Entrants and Expansion Plans
Table 76. Global Genetic Toxicology Revenue (USD Million) by Type (2017-2022)
Table 77. Global Genetic Toxicology Revenue Share by Type (2017-2022)
Table 78. Global Genetic Toxicology Revenue Forecast by Type (2023-2028)
Table 79. Global Genetic Toxicology Revenue by Application (2017-2022)
Table 80. Global Genetic Toxicology Revenue Forecast by Application (2023-2028)
Table 81. North America Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Genetic Toxicology Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Genetic Toxicology Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Genetic Toxicology Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Genetic Toxicology Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Genetic Toxicology Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Genetic Toxicology Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Genetic Toxicology Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Genetic Toxicology Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Genetic Toxicology Picture
Figure 2. Global Genetic Toxicology Revenue Market Share by Type in 2021
Figure 3. Genotoxicity Screening Assays
Figure 4. GLP Standard Genotoxicity Assays
Figure 5. Genetic Toxicology Revenue Market Share by Application in 2021
Figure 6. Mini Ames/Ames Picture
Figure 7. Gene Mutation Picture
Figure 8. In Vitro Micronucleus Picture
Figure 9. Chromosome Aberration Picture
Figure 10. Others Picture
Figure 11. Global Genetic Toxicology Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Genetic Toxicology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Genetic Toxicology Revenue Market Share by Region (2017-2028)
Figure 14. Global Genetic Toxicology Revenue Market Share by Region in 2021
Figure 15. North America Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Genetic Toxicology Market Drivers
Figure 21. Genetic Toxicology Market Restraints
Figure 22. Genetic Toxicology Market Trends
Figure 23. Frontage Laboratories Recent Developments and Future Plans
Figure 24. Accelera Recent Developments and Future Plans
Figure 25. Charles River Recent Developments and Future Plans
Figure 26. Pharmaron Recent Developments and Future Plans
Figure 27. Labcorp Recent Developments and Future Plans
Figure 28. Syngene Recent Developments and Future Plans
Figure 29. Vivotecnia Recent Developments and Future Plans
Figure 30. Technics Recent Developments and Future Plans
Figure 31. Aurigene Pharmaceutical Services Recent Developments and Future Plans
Figure 32. ERBC Group Recent Developments and Future Plans
Figure 33. NextGen Recent Developments and Future Plans
Figure 34. Cardinal Health Recent Developments and Future Plans
Figure 35. Toxys Recent Developments and Future Plans
Figure 36. Abbott Toxicology Recent Developments and Future Plans
Figure 37. Evotec Recent Developments and Future Plans
Figure 38. EPL Recent Developments and Future Plans
Figure 39. Global Genetic Toxicology Revenue Share by Players in 2021
Figure 40. Genetic Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Genetic Toxicology Revenue Market Share in 2021
Figure 42. Global Top 10 Players Genetic Toxicology Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Genetic Toxicology Revenue Share by Type in 2021
Figure 45. Global Genetic Toxicology Market Share Forecast by Type (2023-2028)
Figure 46. Global Genetic Toxicology Revenue Share by Application in 2021
Figure 47. Global Genetic Toxicology Market Share Forecast by Application (2023-2028)
Figure 48. North America Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 49. North America Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 50. North America Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 51. United States Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 55. Europe Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 56. Europe Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 57. Germany Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Genetic Toxicology Revenue Market Share by Region (2017-2028)
Figure 65. China Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 72. South America Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 73. South America Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Genetic Toxicology Picture
Figure 2. Global Genetic Toxicology Revenue Market Share by Type in 2021
Figure 3. Genotoxicity Screening Assays
Figure 4. GLP Standard Genotoxicity Assays
Figure 5. Genetic Toxicology Revenue Market Share by Application in 2021
Figure 6. Mini Ames/Ames Picture
Figure 7. Gene Mutation Picture
Figure 8. In Vitro Micronucleus Picture
Figure 9. Chromosome Aberration Picture
Figure 10. Others Picture
Figure 11. Global Genetic Toxicology Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Genetic Toxicology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Genetic Toxicology Revenue Market Share by Region (2017-2028)
Figure 14. Global Genetic Toxicology Revenue Market Share by Region in 2021
Figure 15. North America Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Genetic Toxicology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Genetic Toxicology Market Drivers
Figure 21. Genetic Toxicology Market Restraints
Figure 22. Genetic Toxicology Market Trends
Figure 23. Frontage Laboratories Recent Developments and Future Plans
Figure 24. Accelera Recent Developments and Future Plans
Figure 25. Charles River Recent Developments and Future Plans
Figure 26. Pharmaron Recent Developments and Future Plans
Figure 27. Labcorp Recent Developments and Future Plans
Figure 28. Syngene Recent Developments and Future Plans
Figure 29. Vivotecnia Recent Developments and Future Plans
Figure 30. Technics Recent Developments and Future Plans
Figure 31. Aurigene Pharmaceutical Services Recent Developments and Future Plans
Figure 32. ERBC Group Recent Developments and Future Plans
Figure 33. NextGen Recent Developments and Future Plans
Figure 34. Cardinal Health Recent Developments and Future Plans
Figure 35. Toxys Recent Developments and Future Plans
Figure 36. Abbott Toxicology Recent Developments and Future Plans
Figure 37. Evotec Recent Developments and Future Plans
Figure 38. EPL Recent Developments and Future Plans
Figure 39. Global Genetic Toxicology Revenue Share by Players in 2021
Figure 40. Genetic Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Genetic Toxicology Revenue Market Share in 2021
Figure 42. Global Top 10 Players Genetic Toxicology Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Genetic Toxicology Revenue Share by Type in 2021
Figure 45. Global Genetic Toxicology Market Share Forecast by Type (2023-2028)
Figure 46. Global Genetic Toxicology Revenue Share by Application in 2021
Figure 47. Global Genetic Toxicology Market Share Forecast by Application (2023-2028)
Figure 48. North America Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 49. North America Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 50. North America Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 51. United States Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 55. Europe Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 56. Europe Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 57. Germany Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Genetic Toxicology Revenue Market Share by Region (2017-2028)
Figure 65. China Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 72. South America Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 73. South America Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Genetic Toxicology Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Genetic Toxicology Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Genetic Toxicology Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Genetic Toxicology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
